<code id='1E04D7CB63'></code><style id='1E04D7CB63'></style>
    • <acronym id='1E04D7CB63'></acronym>
      <center id='1E04D7CB63'><center id='1E04D7CB63'><tfoot id='1E04D7CB63'></tfoot></center><abbr id='1E04D7CB63'><dir id='1E04D7CB63'><tfoot id='1E04D7CB63'></tfoot><noframes id='1E04D7CB63'>

    • <optgroup id='1E04D7CB63'><strike id='1E04D7CB63'><sup id='1E04D7CB63'></sup></strike><code id='1E04D7CB63'></code></optgroup>
        1. <b id='1E04D7CB63'><label id='1E04D7CB63'><select id='1E04D7CB63'><dt id='1E04D7CB63'><span id='1E04D7CB63'></span></dt></select></label></b><u id='1E04D7CB63'></u>
          <i id='1E04D7CB63'><strike id='1E04D7CB63'><tt id='1E04D7CB63'><pre id='1E04D7CB63'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:49
          Cigna logo
          Julia Rendleman/Getty Images for Eventive Marketing

          Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

          The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

          advertisement

          That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Stoke drug shows lower activity against childhood epilepsy
          Stoke drug shows lower activity against childhood epilepsy

          AdobeStokeTherapeuticsisstillseekinganeffectivedoseforanexperimentaldrugtotreatasevereformofchildhoo

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Cassava Sciences’ Alzheimer’s clinical trials should be halted

          MollyFerguson/STATTheFoodandDrugAdministrationshouldhaltCassavaSciences’ongoingclinicaltrialsinAlzhe